Literature DB >> 18184262

The advantage of using a synoptic pathology report format for cutaneous melanoma.

R Z Karim1, K S van den Berg, M H Colman, S W McCarthy, J F Thompson, R A Scolyer.   

Abstract

AIMS: Although the synoptic format is being increasingly used for primary cutaneous melanoma pathology reporting, no study assessing its value has yet been reported in the literature. The aim was to determine whether the use of synoptic reports increases the frequency with which pathological features that may influence prognosis and guide management are documented. METHODS AND
RESULTS: Melanoma pathology reports (n = 1692) were evaluated; 904 were in a synoptic format [671 Sydney Melanoma Unit (SMU) reports and 233 non-SMU reports] and 788 were non-synoptic (184 SMU reports and 604 non-SMU reports). Reports (n = 1354) from 677 patients who had both a SMU report and a non-SMU report were compared. Almost all features were reported more frequently in synoptic than in non-synoptic reports (P < 0.001). No significant differences were found in the frequency of reporting the main pathological features between SMU and non-SMU synoptic reports. Synoptic reports were more frequently used by SMU (78%) than by non-SMU pathologists (28%).
CONCLUSIONS: This is the first study to provide objective evidence that synoptic pathology reports for melanoma are more complete than non-synoptic reports (regardless of whether the reports are generated within or outside a specialist melanoma centre). All synoptic reports should include the facility for free text, be tailored to individual institutional requirements and be updated regularly to be of maximal value.

Entities:  

Mesh:

Year:  2008        PMID: 18184262     DOI: 10.1111/j.1365-2559.2007.02921.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  15 in total

1.  Health System-Level Factors Influence the Implementation of Complex Innovations in Cancer Care.

Authors:  Robin Urquhart; Lois Jackson; Joan Sargeant; Geoffrey A Porter; Eva Grunfeld
Journal:  Healthc Policy       Date:  2015-11

Review 2.  Does standardised structured reporting contribute to quality in diagnostic pathology? The importance of evidence-based datasets.

Authors:  D W Ellis; J Srigley
Journal:  Virchows Arch       Date:  2015-08-28       Impact factor: 4.064

3.  Pitfalls and important issues in the pathologic diagnosis of melanocytic tumors.

Authors:  Stanley W McCarthy; Richard A Scolyer
Journal:  Ochsner J       Date:  2010

4.  Histopathologic synoptic reporting of invasive melanoma: How reliable are the data?

Authors:  Laura A Taylor; Megan M Eguchi; Lisa M Reisch; Andrea C Radick; Hannah Shucard; Kathleen F Kerr; Michael W Piepkorn; Stevan R Knezevich; David E Elder; Raymond L Barnhill; Joann G Elmore
Journal:  Cancer       Date:  2021-05-04       Impact factor: 6.860

5.  Exploring the interpersonal-, organization-, and system-level factors that influence the implementation and use of an innovation-synoptic reporting-in cancer care.

Authors:  Robin Urquhart; Geoffrey A Porter; Eva Grunfeld; Joan Sargeant
Journal:  Implement Sci       Date:  2012-03-01       Impact factor: 7.327

6.  Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR).

Authors:  Richard A Scolyer; Meagan J Judge; Alan Evans; David P Frishberg; Victor G Prieto; John F Thompson; Martin J Trotter; Maureen Y Walsh; Noreen M G Walsh; David W Ellis
Journal:  Am J Surg Pathol       Date:  2013-12       Impact factor: 6.394

7.  Compliance with reporting guidelines by Australian pathologists: an audit of the quality of histopathology reporting in high-grade glioma.

Authors:  Alison White; Vicki Fabian; Kerrie McDonald; Anna K Nowak
Journal:  Neurooncol Pract       Date:  2015-08-26

8.  Development of a synoptic MRI report for primary rectal cancer.

Authors:  Gillian Spiegle; Marisa Leon-Carlyle; Selina Schmocker; Mark Fruitman; Laurent Milot; Anna R Gagliardi; Andy J Smith; Robin S McLeod; Erin D Kennedy
Journal:  Implement Sci       Date:  2009-12-02       Impact factor: 7.327

9.  Multi-level factors influence the implementation and use of complex innovations in cancer care: a multiple case study of synoptic reporting.

Authors:  Robin Urquhart; Geoffrey A Porter; Joan Sargeant; Lois Jackson; Eva Grunfeld
Journal:  Implement Sci       Date:  2014-09-16       Impact factor: 7.327

Review 10.  The effects of implementing synoptic pathology reporting in cancer diagnosis: a systematic review.

Authors:  Caro E Sluijter; Luc R C W van Lonkhuijzen; Henk-Jan van Slooten; Iris D Nagtegaal; Lucy I H Overbeek
Journal:  Virchows Arch       Date:  2016-04-21       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.